Omeros reported $590.97M in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acelrx Pharmaceuticals ACRX:US USD 48.31M 7.82M
Adma Biologics ADMA:US USD 348.46M 47.9M
Alnylam Pharmaceuticals ALNY:US USD 3.55B 11.1M
Biomarin Pharmaceutical BMRN:US USD 6.38B 111.03M
Cytokinetics CYTK:US USD 1.01B 61.19M
Dynavax Technologies DVAX:US USD 985.85M 13.49M
Gilead Sciences GILD:US USD 63.17B 614M
Heron Therapeutics HRTX:US USD 250.95M 21M
Insmed INSM:US USD 1.66B 661.62M
Intercept Pharmaceuticals ICPT:US USD 553.71M 5.69M
Knight Therapeutics Inc GUD:CN CAD 1.05B 19.49M
Macrogenics MGNX:US USD 280.47M 85.12M
Mirati Therapeutics MRTX:US USD 1.2B 100.44M
Omeros OMER:US USD 590.97M 133.42M
Pacira Pharmaceuticals PCRX:US USD 1.68B 53.16M
Regulus Therapeutics RGLS:US USD 46.72M 5.41M
Rockwell Medical RMTI:US USD 54.19M 4.93M
Sangamo Biosciences SGMO:US USD 562.51M 31.4M
Sarepta Therapeutics SRPT:US USD 3.13B 27.78M
United Therapeutics UTHR:US USD 6.04B 262.9M
Vertex Pharmaceuticals VRTX:US USD 18.15B 1.44B
Vital Therapies VTL:US USD 127.75M 6.67M